Instil Bio Inc reports results for the quarter ended in September - Earnings Summary

Instil Bio

14/11/2022 23:09

* Instil Bio Inc  TIL.OQ  reported a quarterly adjusted loss
of 43
cents​​ per share for the quarter ended in September. The mean
expectation of five analysts for the quarter was for a loss
of 44 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Instil Bio Inc's reported EPS for the quarter was a loss
of 43
cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.9%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Instil Bio Inc shares had fallen by 53.3% this quarter and
lost 86.8% so far this year.
    * The company reported a quarterly loss of $56.22 million.
    * Wall Street's median 12-month price target for Instil Bio
Inc is
$14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 11:08 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.44          -0.43          Beat
 Jun. 30 2022      -0.41          -0.46          Missed
 Mar. 31 2022      -0.38          -0.42          Missed
 Dec. 31 2021      -0.36          -0.43          Missed